Back to Site
Managing urological cancers has undergone many developments and refinements over the past decade which includes Da Vinci robot assisted surgery. Using the most advanced technology available today, the Da Vinci® Si Surgical System, Dr. T. B. Yuvaraja and his team at Kokilaben Dhirubhai Ambani Hospital have performed more than 325 surgeries for cancers of urinary tract. This includes robotic radical prostatectomy for prostate cancer, robotic partial and total nephrectomy for kidney cancers and robotic radical cystectomy for urinary bladder cancer including total intracorporeal urinary diversions like neo bladder and ileal conduit etc. The expertise and experience of the surgeon evaluating and treating the cancer patient is one of the keys to the overall outcome and cure of the patient. Our surgeons are highly experienced in all modality of surgery like open, laparoscopic and robotic surgery giving the patients very high standard of care.
Kokilaben Hospital is one of the first hospitals to offer minimally invasive robotic prostatectomy. The challenge for the surgeon is how best to remove the cancer while sparing the nerves and surrounding anatomy in order to preserve sexual and urinary function. Looking critically into literature robotic surgery offers the best way to achieve this with minimum morbidity to the patients. This technology produces better results in controlling cancer, plus related incontinence and impotence, compared to traditional methods.
Managing kidney tumors have dramatically changed in the last decade with kidney sparing surgeries in the form of partial nephrectomy and robotic approach becoming the standard of care and hence fewer patients lose their kidney in surgery. Recent evidence suggests that robotic partial nephrectomy offers equivalent oncological control to open and laparoscopic approach while providing the additional benefit of shorter hospital stay, less intraoperative blood loss and less damage to the kidney.
Robot-assisted radical cystectomy (RARC) offers an attractive minimally invasive alternative to the current gold standard of open radical cystectomy for muscle-invasive bladder cancer and highrisk non-muscle-invasive disease. This offers excellent cancer control and acceptable complication rates compared to open surgery with all the benefits of minimally invasive surgery. RARC is an evolving technique that affords patients and physicians alike an efficacious minimally invasive treatment option in the treatment of bladder cancer
